Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUREFIRE RESOURCES NL Director's Dealing 2006

Dec 11, 2006

65857_rns_2006-12-11_56314afb-d25c-45f3-abbb-9158658ded88.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Genesis Biomedical Limited
ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Donald Lawrence Valentino
Date of last notice 30 May 2006

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Transfer from Direct to Indirect
Nature of indirect interest
(including registered holder)
Transfer of:
Note: Provide details of the circumstances giving rise to the relevant
interest.
600,000 Fully Paid Ordinary Shares
600,000 Options \$0.03, 30 November 2010
Via the following registered holder:
From: Mr Donald Lawrence Valentino
To: Donald Lawrence Valentino & Judith
Ann Valentino (Valo Super Plan)
Date of change 7 December 2006
No. of securities held prior to change 4,798,267 Fully Paid Ordinary Shares
4,498,267 Options \$0.03, 30 November 2010
Class Ordinary Shares
Options \$0.03, 30 November 2010
Number transfered 600,000 Fully Paid Ordinary shares
600,000 Options \$0.03, 30 November 2010
Number disposed Nil

+ See chapter 19 for defined terms.

Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation-
Nil, no change to beneficial owner
No. of securities held after change 4,798,267 Fully Paid Ordinary Shares
4,498,267 Options \$0.03, 30 November 2010
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back-
Off market transfer

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N i
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change

$\overline{\text{+ See chapter 19}}$ for defined terms.